US Patent Issued to DENALI THERAPEUTICS on June 30 for "Formulations of protein molecules comprising iduronate 2-sulfatase" (California Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,606, issued on June 30, was assigned to DENALI THERAPEUTICS INC. (South San Francisco, Calif.).

"Formulations of protein molecules comprising iduronate 2-sulfatase" was invented by Dana Andersen (South San Francisco, Calif.), Adam Catherman (South San Francisco, Calif.), Tina Giese (South San Francisco, Calif.), Gunasekaran Kannan (South San Francisco, Calif.), Mihalis S. Kariolis (South San Francisco, Calif.), Cathal S. Mahon (South San Francisco, Calif.) and Ankit Patel (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Certain embodiments provide a pharmaceutical composition comprising: a protein molecule comprising an ER...